Development of a high affinity Affibody-derived protein against amyloid β-peptide for future Alzheimer's disease therapy

Biotechnology Journal

Volumn 10, Issue 11, 2015, Pages 1668-1669

  De Genst, Erwin ^a   Muyldermans, Serge ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AFFIBODY DERIVED PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; BETA SECRETASE 1; GAMMA SECRETASE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ALZHEIMER DISEASE; ANTIBODY AFFINITY; BLOOD BRAIN BARRIER; CODON; DISSOCIATION; DRUG COMPETITION; DRUG EFFICACY; HUMAN; MACROMOLECULE; MUTATION RATE; NONHUMAN; NOTE; PASSIVE IMMUNIZATION; PHAGE DISPLAY; PRIORITY JOURNAL; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; HUMANS;

EID: 84947031613     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201500405     Document Type: Note

References (10)

1. Bohm, C., Chen, F., Sevalle, J., Qamar, S. et al., Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways. Mol. Cell. Neurosci. 2015, 66, 3-11.
2. Lindberg, H., Härd, T., Löfblom, J., Ståhl, S., A truncated and dimeric format of an affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity. Biotechnol J. 2015, DOI 10.1002/biot.201500131.10.1002/biot.201500131.,
3. Knowles, T. P. J., Vendruscolo, M., Dobson, C.M., The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 2014, 15, 384-396.
4. Löfblom, J., Frejd, F.Y., Ståhl, S., Non-immunoglobulin based protein scaffolds. Curr. Opin. Biotechnol. 2011, 22, 843-848.
5. Grönwall, C., Jonsson, A., Lindström, S., Gunneriussan, E. et al., Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides. Biotechn. J. 2007, 128, 162-183.
6. Hoyer, W., Grönwall, C., Jonsson, A., Ståhl, S., Härd, T., Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation. Proc. Natl. Acad. Sci. USA 2008, 105, 5099-5104.
7. Luheshi, L.M., Hoyer, W., Pereira de Barros, T., van Dijk Härd, I. et al., Sequestration of the Aβ peptide prevents toxicity and promotes degradation in vivo. PLoS Biol. 2010, 8, e1000334.
8. Obermeier, B., Daneman, R., Ransohoff, R. M., Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 2013, 19, 1584-1596.
9. Yu, Y.J., Atwal, J.K., Zhang, Y., Tong, R.K. et al., Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates. Sci. Transl. Med. 2014, 6, 261ra154.
10. Frank, R.T., Aboody, K.S., Najbauer, J., Strategies for enhancing antibody delivery to the brain. Biochim. Biophys. Acta BBA - Rev. Cancer 2011, 1816, 191-198.